Our industry is now, more than ever, ready to move to decentralized trials (DCT) and design hybrid protocols that support trial continuity and have a more patient-centric approach.
Through discussions with our clients, it’s clear that most sponsors have struggled to implement DCT and need an innovative, modern technology platform that enables more efficient and future-ready trial processes.
The unique architecture of encapsia brings the technology to the data and provides an agile, revolutionary way to support decentralized clinical trial.
As the industry accelerates the adoption of new technologies, now is the time you need a modern DCT platform: powerful, flexible and innovative. Take control of your clinical data and remove the barriers to trial continuity.
Step forward with encapsia and let us demonstrate how choosing the right technology can transform your trials of tomorrow.